18 Own capitalized costs

Own capitalized costs amounted to EUR 2.3 billion in the reporting year (2016: EUR 2.1 billion; 2015: EUR 2.0 billion) and mainly relate to ¬≠investments in network build-out and the development of platforms for cell sites.